Stockreport

Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics [Yahoo! Finance]

Invitae Corporation  (NVTA) 
Last invitae corporation earnings: 2/19 04:05 pm Check Earnings Report
PDF Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, designed to advance genetics-based drug discovery for [Read more]